日科化学(300214) - 2021 Q1 - 季度财报

Financial Performance - The company's revenue for Q1 2021 was CNY 577,964,663.37, representing a 17.00% increase compared to CNY 493,966,210.05 in the same period last year[8]. - Net profit attributable to shareholders decreased by 32.03% to CNY 38,249,194.58 from CNY 56,277,569.45 year-on-year[8]. - Basic and diluted earnings per share fell by 30.77% to CNY 0.09 from CNY 0.13 in the same period last year[8]. - The gross profit margin decreased by 6.99 percentage points compared to the same period last year due to fluctuations in raw material prices[24]. - The company reported a significant increase in revenue for Q1 2021, with a year-over-year growth of 15%[39]. - The total profit for the current period was ¥49,023,644.52, down 34.06% from ¥74,440,797.31 in the previous period[56]. Cash Flow - The net cash flow from operating activities dropped significantly by 74.58% to CNY 28,476,879.90, down from CNY 112,015,906.86 in the previous year[8]. - The net cash flow from operating activities was CNY -10,611,580.16, compared to -12,411,046.80 in the previous period, indicating an improvement[67]. - Total cash inflow from operating activities was 236,410,199.52 CNY, up from 147,634,592.98 CNY year-over-year[67]. - The net cash flow from investing activities was -24,698,054.86, reflecting a significant increase in project construction expenditures[23]. - The net cash flow from financing activities was CNY -35,709,615.91, a 53.27% improvement compared to the previous year, as the company did not obtain financing from financial institutions[23]. Assets and Liabilities - Total assets increased by 1.56% to CNY 2,304,596,450.06 compared to CNY 2,269,233,836.41 at the end of the previous year[8]. - Total liabilities increased to CNY 379,071,057.52 from CNY 346,267,223.09, reflecting an increase of about 9.5%[49]. - The company's total equity as of March 31, 2021, was CNY 1,925,525,392.54, slightly up from CNY 1,922,966,613.32, indicating a marginal increase of about 0.13%[50]. Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 15,156, with no repurchase transactions conducted during the period[12][13]. - The company confirmed no non-operating fund occupation by controlling shareholders during the reporting period[42]. Strategic Initiatives - The company acquired 100% equity of Shandong Huibin Cotton Spinning and Dyeing Co., Ltd. for a transaction price of 77.08 million RMB, with the aim to revitalize its chlor-alkali production capacity[32]. - The acquisition of Shandong Huibin is part of the company's strategic development to extend upstream in the industry chain[32]. - The company is actively pursuing a simplified procedure for issuing stocks to specific targets to raise funds, pending approval from the Shenzhen Stock Exchange and the China Securities Regulatory Commission[33]. - The stock issuance plan is subject to uncertainties regarding the approval and registration timeline from regulatory bodies[33]. Risks and Challenges - The company faces risks from raw material price fluctuations, intensified competition, and investment project uncertainties, which may impact future profitability[27][28][29]. - The company reported an estimated financial loss of approximately 11.63 million RMB due to embezzlement by a financial staff member, and has made provisions for bad debts accordingly[36]. - The company has not identified any other security incidents related to funds following the embezzlement case and has strengthened its financial management system[36]. Future Outlook - The company provided a positive outlook for the upcoming quarters, projecting a revenue growth of 10% to 15% for the full year 2021[39]. - New product launches are expected to contribute an additional 5% to revenue growth in the next quarter[39]. - Market expansion plans include entering two new international markets by the end of Q3 2021[39]. - The company is considering strategic acquisitions to enhance its product portfolio, with a focus on companies in the chemical sector[39].